United States · Who invested in Angitia Biopharmaceuticals?
Angitia Biopharmaceuticals's investors include RA Capital Management, Wellington Management, BlackRock, Legend Capital and Hill House Capital, and 1 more on record.
United States · Series D startup
Who invested in Angitia Biopharmaceuticals
Funding summaryUpdated 26 Oct 2026
$130Mraised across 1 round since 2026, from 1 source
- Latest round
- Series D, $130MFeb 2026
- Investors
- 6
The rounds
- Feb 2026Series D$130M
RA Capital Management
Wellington Management
BlackRock
Legend Capital
Hill House Capital
Janus Henderson Investors
Source recorded
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Angitia Biopharmaceuticals
How much has Angitia Biopharmaceuticals raised?
Angitia Biopharmaceuticals has raised $130M across 1 round since 2026.
When did Angitia Biopharmaceuticals last raise?
Angitia Biopharmaceuticals's most recent round was a Series D of $130M in Feb 2026.
What was Angitia Biopharmaceuticals's biggest round?
Its most recent round, $130M in Feb 2026, is also its largest on record.
Who backed Angitia Biopharmaceuticals first?
Angitia Biopharmaceuticals's first round on record, in Feb 2026, was backed by RA Capital Management, Wellington Management and BlackRock and 3 others.
What stage is Angitia Biopharmaceuticals at?
Angitia Biopharmaceuticals's latest named round is a Series D, in Feb 2026.
Where is Angitia Biopharmaceuticals based?
Angitia Biopharmaceuticals is based in the United States.
Companies like Angitia Biopharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.